Invention Grant
US08623365B2 Aβ binding molecules 有权
Abeta结合分子

Aβ binding molecules
Abstract:
The present invention encompasses isolated antibodies, or fragments thereof, that are humanized variants of murine antibody 266 which employ complementarity determining regions derived from murine antibody 266. The variant antibodies are useful for treatment or prevention of conditions and diseases associated with Aβ, including Alzheimer's disease, Down's syndrome, cerebral amyloid angiopathy, mild cognitive impairment, and the like.
Public/Granted literature
Information query
Patent Agency Ranking
0/0